News & Updates

Semaglutide helps overweight schizophrenia patients on clozapine lose weight safely

19 Jun 2025

For patients with schizophrenia being treated with clozapine who have high BMI, semaglutide delivers weight-loss benefits without affecting psychotic symptoms or altering clozapine concentrations, according to the double-blind, phase II COaST study.

Semaglutide helps overweight schizophrenia patients on clozapine lose weight safely

19 Jun 2025

Sildenafil does not improve perinatal outcomes related to hypoxia during labour

18 Jun 2025

Treatment with sildenafil citrate during labour falls short of reducing the incidence of adverse perinatal outcomes potentially related to intrapartum hypoxia, according to a study.

Sildenafil does not improve perinatal outcomes related to hypoxia during labour

18 Jun 2025

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

18 Jun 2025 by

The investigational influenza–COVID-19 combination vaccine mRNA-1083 has demonstrated noninferiority to recommended standard-care flu and COVID-19 vaccines, with higher immune responses and an acceptable safety profile in adults at least 50 years of age, according to the results of a phase III trial.

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

18 Jun 2025

First-line methotrexate on par with prednisone for sarcoidosis

18 Jun 2025 by

The use of methotrexate as a first line of treatment for patients with pulmonary sarcoidosis delivers similar efficacy to prednisone as measured by forced vital capacity after 24 weeks, results of the PREDMETH trial have shown.

First-line methotrexate on par with prednisone for sarcoidosis

18 Jun 2025

Digital therapy improves life quality of patients with pulmonary fibrosis

18 Jun 2025 by

A novel digital psychological therapy, named Almee, demonstrates efficacy in improving health-related quality of life (HRQOL) in patients with pulmonary fibrosis, irrespective of antifibrotic treatment use, reports a study presented at ATS 2025.

Digital therapy improves life quality of patients with pulmonary fibrosis

18 Jun 2025

Inclisiran superior to ezetimibe in LDL-C reduction in patients without ASCVD

18 Jun 2025

Treatment with inclisiran monotherapy demonstrates good tolerability and better reduction in low-density lipoprotein cholesterol (LDL-C) levels when compared with ezetimibe and placebo in patients without atherosclerotic cardiovascular disease (ASCVD), reports a study.

Inclisiran superior to ezetimibe in LDL-C reduction in patients without ASCVD

18 Jun 2025

RSV-ARI nearly triples mortality risk in new study

18 Jun 2025 by

Acute respiratory infection caused by respiratory syncytial virus (RSV-ARI) nearly triples the risk of death, particularly among individuals with chronic underlying respiratory conditions, as shown in a nationwide cohort study in Denmark.

RSV-ARI nearly triples mortality risk in new study

18 Jun 2025

Coil plus glue therapy beneficial for gastric varices

18 Jun 2025 by

Cyanoacrylate (CYA) injection delivers better results when augmented with endoscopic ultrasonography (EUS)-guided coil embolization for gastric variceal obliteration in a single-centre study.

Coil plus glue therapy beneficial for gastric varices

18 Jun 2025

Adalimumab delivers consistent benefit in plaque psoriasis, with or without methotrexate

18 Jun 2025

Treatment outcomes with adalimumab for plaque psoriasis appear to be similar between patients on monotherapy and those receiving concomitant methotrexate, according to the BSTOP study.

Adalimumab delivers consistent benefit in plaque psoriasis, with or without methotrexate

18 Jun 2025

Ferric carboxymaltose infusion offers little help in iron-deficient patients with heart failure

17 Jun 2025

Intravenous ferric carboxymaltose does not appear to be beneficial in terms of heart failure (HF) hospitalization and cardiovascular mortality in patients with HF and iron deficiency, according to a study.

Ferric carboxymaltose infusion offers little help in iron-deficient patients with heart failure

17 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

Semaglutide helps overweight schizophrenia patients on clozapine lose weight safely

Semaglutide helps overweight schizophrenia patients on clozapine lose weight safely

Sildenafil does not improve perinatal outcomes related to hypoxia during labour

Sildenafil does not improve perinatal outcomes related to hypoxia during labour

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

First-line methotrexate on par with prednisone for sarcoidosis

First-line methotrexate on par with prednisone for sarcoidosis

Digital therapy improves life quality of patients with pulmonary fibrosis

Digital therapy improves life quality of patients with pulmonary fibrosis

Inclisiran superior to ezetimibe in LDL-C reduction in patients without ASCVD

Inclisiran superior to ezetimibe in LDL-C reduction in patients without ASCVD

RSV-ARI nearly triples mortality risk in new study

RSV-ARI nearly triples mortality risk in new study

Coil plus glue therapy beneficial for gastric varices

Coil plus glue therapy beneficial for gastric varices

Adalimumab delivers consistent benefit in plaque psoriasis, with or without methotrexate

Adalimumab delivers consistent benefit in plaque psoriasis, with or without methotrexate

Ferric carboxymaltose infusion offers little help in iron-deficient patients with heart failure

Ferric carboxymaltose infusion offers little help in iron-deficient patients with heart failure